Recently, it has been shown that the PAX5-P80R mutation induces a unique transcriptional program in patients, defining an independent B-ALL subtype and supporting the notion that PAX5-P80R is an initiating lesion in the process of leukemogenesis [190,191,192,193]. Here, PAX5 is linked to acute lymphoblastic leukemia.